A 4642 New Jersey General Assembly · 2026-2027 Regular Session

Clarifies that testosterone therapy is covered treatment under the "New Jersey Menopause Coverage Act."

This bill clarifies that testosterone therapy is covered under New Jersey's existing Menopause Coverage Act for women diagnosed with perimenopause or menopause. It requires health insurance plans to provide testosterone therapy to the same extent as other hormonal treatments, even if the FDA has not specifically approved it for these conditions. The legislation also mandates that insurers provide clear information about covered menopause treatments and includes other services like non-hormonal medications, behavioral health care, pelvic floor physical therapy, and bone health treatments. This change directly affects women in New Jersey who use testosterone therapy for menopausal symptoms and the insurance companies that cover their healthcare.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 10, 2026 Last action Mar 10, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Mar 10, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
2 primary · 0 co-sponsors

Sponsors